246 related articles for article (PubMed ID: 20145041)
1. Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation.
Wang J; Kuiatse I; Lee AV; Pan J; Giuliano A; Cui X
Mol Cancer Res; 2010 Feb; 8(2):266-77. PubMed ID: 20145041
[TBL] [Abstract][Full Text] [Related]
2. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
Eriksson M; Taskinen M; Leppä S
J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
[TBL] [Abstract][Full Text] [Related]
3. c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.
Madeo A; Vinciguerra M; Lappano R; Galgani M; Gasperi-Campani A; Maggiolini M; Musti AM
Oncogene; 2010 Feb; 29(7):978-91. PubMed ID: 19935718
[TBL] [Abstract][Full Text] [Related]
4. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression.
Chen H; Zhu G; Li Y; Padia RN; Dong Z; Pan ZK; Liu K; Huang S
Cancer Res; 2009 Dec; 69(24):9228-35. PubMed ID: 19920183
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis.
Zuo J; Ishikawa T; Boutros S; Xiao Z; Humtsoe JO; Kramer RH
Mol Cancer Res; 2010 Feb; 8(2):170-82. PubMed ID: 20145039
[TBL] [Abstract][Full Text] [Related]
6. c-Jun N-terminal kinase activity supports multiple phases of 3D-mammary epithelial acinus formation.
McNally S; McArdle E; Gilligan E; Napoletano S; Gajewska M; Bergin O; McCarthy S; Whyte J; Bianchi A; Stack J; Martin F
Int J Dev Biol; 2011; 55(7-9):731-44. PubMed ID: 22161830
[TBL] [Abstract][Full Text] [Related]
7. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells.
Doehn U; Hauge C; Frank SR; Jensen CJ; Duda K; Nielsen JV; Cohen MS; Johansen JV; Winther BR; Lund LR; Winther O; Taunton J; Hansen SH; Frödin M
Mol Cell; 2009 Aug; 35(4):511-22. PubMed ID: 19716794
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
9. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
10. Mechanical force induces type I collagen expression in human periodontal ligament fibroblasts through activation of ERK/JNK and AP-1.
Kook SH; Hwang JM; Park JS; Kim EM; Heo JS; Jeon YM; Lee JC
J Cell Biochem; 2009 Apr; 106(6):1060-7. PubMed ID: 19206162
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
13. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
14. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
Lin CW; Yang LY; Shen SC; Chen YC
J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Signal-Regulated Protein Kinase, c-Jun N-Terminal Protein Kinase, and Calcineurin Regulate Transient Receptor Potential M3 (TRPM3) Induced Activation of AP-1.
Lesch A; Rössler OG; Thiel G
J Cell Biochem; 2017 Aug; 118(8):2409-2419. PubMed ID: 28112420
[TBL] [Abstract][Full Text] [Related]
16. JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses.
Sundqvist A; Voytyuk O; Hamdi M; Popeijus HE; van der Burgt CB; Janssen J; Martens JWM; Moustakas A; Heldin CH; Ten Dijke P; van Dam H
Cells; 2019 Nov; 8(12):. PubMed ID: 31766464
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways.
Hahn M; Li W; Yu C; Rahmani M; Dent P; Grant S
Mol Cancer Ther; 2005 Mar; 4(3):457-70. PubMed ID: 15767555
[TBL] [Abstract][Full Text] [Related]
18. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells.
Lee CC; Chen SC; Tsai SC; Wang BW; Liu YC; Lee HM; Shyu KG
J Biomed Sci; 2006 Jan; 13(1):143-56. PubMed ID: 16328781
[TBL] [Abstract][Full Text] [Related]
19. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
